This is also evident in the involvement of NFκB in the changes between macrophage phenotypes during inflammation and cancer, leading to the proposal to reshape experimentally and ultimately therapeutically the tumor microenvironment via terminating macrophage recruitment [158]. Here, NFKB1 is linked to neoplasm.